{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T04:19:32Z","timestamp":1744431572553,"version":"3.40.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jiac.2025.102645","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:09:56Z","timestamp":1738800596000},"page":"102645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Isepamicin alone as antimicrobial prophylaxis for transrectal prostate needle biopsy: \u201cDo we still need levofloxacin? \u201d"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7814-8750","authenticated-orcid":false,"given":"Hiroki","family":"Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kojiro","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2164-0899","authenticated-orcid":false,"given":"Hajime","family":"Ohnuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Yasue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahito","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7799-669X","authenticated-orcid":false,"given":"Kei-Ichiro","family":"Miyajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mimu","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Takiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kiyota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jiac.2025.102645_bib1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jiac.2016.05.002","article-title":"A case of infective endocarditis and pyogenic spondylitis after transrectal ultrasound guided prostate biopsy","volume":"22","author":"Hiyama","year":"2016","journal-title":"J Infect Chemother"},{"issue":"4","key":"10.1016\/j.jiac.2025.102645_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jiac.2024.01.011","volume":"30","author":"Wada","year":"2024","journal-title":"J Infect Chemother"},{"issue":"7","key":"10.1016\/j.jiac.2025.102645_bib3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jiac.2024.03.024","article-title":"Fourth national Japanese antimicrobial susceptibility pattern surveillance program: bacterial isolates from patients with complicated urinary tract infections","volume":"30","author":"Kobayashi","year":"2024","journal-title":"J Infect Chemother"},{"issue":"10","key":"10.1016\/j.jiac.2025.102645_bib4","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/iju.13161","article-title":"Essential Japanese guidelines for the prevention of perioperative infections in the urological field: 2015 edition","volume":"23","author":"Yamamoto","year":"2016","journal-title":"Int J Urol"},{"issue":"1","key":"10.1016\/j.jiac.2025.102645_bib5","first-page":"2533","article-title":"A prospective randomized trial comparing a combined regimen of amikacin and levofloxacin to levofloxacin alone as prophylaxis in transrectal prostate needle biopsy","volume":"13","author":"Miyazaki","year":"2016","journal-title":"Urol J"},{"issue":"7","key":"10.1016\/j.jiac.2025.102645_bib6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/iju.13369","article-title":"Prevention of infectious complications after prostate biopsy procedure","volume":"24","author":"Togo","year":"2017","journal-title":"Int J Urol"},{"issue":"3","key":"10.1016\/j.jiac.2025.102645_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2165\/00003088-200038030-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of isepamicin","volume":"38","author":"Tod","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jiac.2025.102645_bib8","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/iju.13161","article-title":"Japanese Research Group for UTI: essential Japanese guidelines for the prevention of perioperative infections in the urological field: 2015 edition","volume":"23","author":"Yamamoto","year":"2016","journal-title":"Int J Urol"},{"issue":"5","key":"10.1016\/j.jiac.2025.102645_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jiac.2019.01.004","article-title":"Efficacy of combined prophylactic use of levofloxacin and isepamicin for transrectal prostate needle biopsy: a retrospective single-center study","volume":"25","author":"Nakagawa","year":"2019","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102645_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.urology.2020.06.005","article-title":"A systematic review and meta-analysis of methods used to reduce infectious complications following transrectal prostate biopsy","volume":"144","author":"Jazayeri","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.jiac.2025.102645_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eururo.2024.03.035","article-title":"European association of Urology guidelines on urological infections: summary of the 2024 guidelines","volume":"86","author":"Kranz","year":"2024","journal-title":"Eur Urol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2500042X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2500042X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T02:15:54Z","timestamp":1744424154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X2500042X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1341321X2500042X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102645","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isepamicin alone as antimicrobial prophylaxis for transrectal prostate needle biopsy: \u201cDo we still need levofloxacin? \u201d","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102645"}}